MarketPulse — Real-Time Financial News & Market Analysis

Citius Oncology reports maiden revenue of $3.9M from LYMPHIR immunotherapy launch in December 2025, marking transition to commercial-stage biopharmaceutical company.

Meltwater secures official Reddit data partnership to provide enterprise analytics on 121M daily users, enabling brands to monitor sentiment and trends from Reddit discussions.

Citius Pharma reports first revenue of $3.9M from LYMPHIR™ launch, raises $20.9M to support growth and advance pipeline candidates.

Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.

Aardvark Therapeutics granted 152,338 stock options to six new hires with exercise prices of $13.48-$12.67, vesting over four years with a one-year cliff.

Law firm Kaskela initiates shareholder investigation into Priority Technology over 50% stock decline since February, examining potential securities violations and fiduciary duty breaches.

Law firm investigates Clearwater Analytics' $24.55/share PE acquisition, questioning if price fairly values shareholders given prior analyst targets above $35.

Dycom Industries will present FY2026 results on March 4, 2026, via conference call at 9:00 a.m. ET, with a press release and Q&A session for investors.

Three dividend aristocrats—Coca-Cola, Verizon, and Realty Income—offer stable income streams across consumer staples, telecom, and real estate sectors for long-term investors.

Soleus Capital significantly increased its Celcuity stake to 1.8 million shares, making it their third-largest position worth $180 million as the biotech stock surged 745% yearly.

Alphabet on track for $5T valuation by 2027 driven by AI adoption. Google Search hit record $63.1B quarterly revenue; Cloud division surged 48% year-over-year.

QLD offers tech-focused 2x leverage with higher volatility; SSO provides diversified S&P 500 exposure with lower costs. Both suited for tactical, short-term trading, not long-term investing.

Starbucks and PepsiCo emerge as strong dividend plays, offering 2.51% and 3.52% yields respectively. Starbucks provides growth momentum while PepsiCo delivers stability through 60 years of consecutive dividend increases.

XDC Network partners with OrbitX Pay to enable USDC spending at 150M+ Visa merchants globally, allowing direct stablecoin transactions without currency conversion.

Matthews International founder G. Paul Matthews and Executive Chairman Mark Headley assume controlling equity stakes, returning firm to independent ownership. New Portfolio Manager appointed.

ANI Pharmaceuticals will report 2025 results on February 27, 2026, reaffirming confidence in meeting or exceeding guidance for revenues, EBITDA, and earnings per share.

Pfizer's 6.3% dividend yield depends on GLP-1 drug success and managing upcoming patent cliffs as it competes against rivals Novo Nordisk and Eli Lilly in obesity treatments.

S&P 500 valuations match dot-com era levels, but today's tech giants like Amazon and Microsoft have real earnings supporting prices, unlike the 1990s bubble.

Tech giants commit $700B to AI infrastructure spending, benefiting Nvidia as GPU demand surges for large-scale AI and data center operations.

Hormel Foods and McCormick emerge as defensive dividend stocks offering stability and consistent income during market uncertainty, with strong downside protection track records.